-
Pediatric CAR T-Cell Immunotherapy Trial Aims to Improve Remission Rates of Leukemia at Children's National Health System
firstwordpharma
June 12, 2019
Children's National Health System today announced the opening of a unique chimeric antigen receptor (CAR) T-cell immunotherapy trial for pediatric patients with relapsed positive acute lymphoblastic leukemia (ALL).
-
Recommendations Developed for Pediatric Multiple Sclerosis Trials
drugs
June 03, 2019
Recommendations Developed for Pediatric Multiple Sclerosis Trials.
-
Pediatric Nurse Practitioner Shortage Looming
drugs
May 31, 2019
Pediatric Nurse Practitioner Shortage Looming.
-
FDA approves first treatment for pediatric patients with lupus
worldpharmanews
April 28, 2019
The U.S. Food and Drug Administration approved Benlysta (belimumab) intravenous (IV) infusion for treatment of children with systemic lupus erythematosus (SLE) - often referred to as simply "lupus"
-
FDA approves first treatment for pediatric patients with lupus
worldpharmanews
April 28, 2019
FDA approves first treatment for pediatric patients with lupus.
-
Halo Pharma Forms Pediatric Center of Excellence
contractpharma
May 11, 2017
Will be dedicated to the development, reformulation, and manufacturing of drug products in pediatric dosage forms
-
The Mikey Czech Foundation Contributes $1 Million To DIPG Research At Dana-Farber Cancer Institute
en-cphi.cn
March 30, 2017
The Mikey Czech Foundation, Inc. announced a $1,000,000 gift to Pediatric Medical Neuro-Oncology at Dana-Farber, headed by Mark W. Kieran, MD, PhD, and located in Boston, Massachusetts.
-
Study reveals promising new strategy to attack deadly pediatric brain tumor
news-medical.net
March 08, 2017
Researchers from Northwestern Medicine and Ann & Robert H. Lurie Children's Hospital of Chicago have revealed new insight into how the most deadly pediatric brain tumor, diffuse intrinsic pontine glioma (DIPG), may develop.